CME Group (NASDAQ:CME) Reaches New 52-Week High at $208.15

CME Group Inc (NASDAQ:CME) shares reached a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $208.15 and last traded at $207.85, with a volume of 108675 shares changing hands. The stock had previously closed at $201.88.

Several analysts recently issued reports on CME shares. Wells Fargo & Co boosted their price target on CME Group from $176.00 to $200.00 and gave the company a “market perform” rating in a research note on Wednesday, July 3rd. ValuEngine upgraded CME Group from a “hold” rating to a “buy” rating in a research note on Wednesday, May 8th. Rosenblatt Securities downgraded CME Group from a “neutral” rating to a “sell” rating in a research note on Thursday, April 18th. Barclays lifted their price objective on CME Group from $191.00 to $197.00 and gave the company an “overweight” rating in a report on Thursday, May 23rd. Finally, Bank of America set a $180.00 price objective on CME Group and gave the company a “hold” rating in a report on Tuesday, April 9th. Three research analysts have rated the stock with a sell rating, five have issued a hold rating and eight have given a buy rating to the company. The company presently has a consensus rating of “Hold” and an average price target of $192.14.

The stock has a market cap of $73.25 billion, a price-to-earnings ratio of 30.55, a P/E/G ratio of 4.58 and a beta of 0.23. The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.04 and a current ratio of 1.05. The stock has a 50-day simple moving average of $201.27.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, July 31st. The financial services provider reported $1.76 earnings per share for the quarter, topping analysts’ consensus estimates of $1.75 by $0.01. CME Group had a return on equity of 9.14% and a net margin of 39.36%. The business had revenue of $1.27 billion for the quarter, compared to analyst estimates of $1.27 billion. During the same quarter in the previous year, the company posted $1.74 EPS. CME Group’s quarterly revenue was up 20.1% compared to the same quarter last year. On average, sell-side analysts predict that CME Group Inc will post 6.66 earnings per share for the current fiscal year.

In related news, Director Timothy S. Bitsberger sold 700 shares of the company’s stock in a transaction dated Tuesday, June 4th. The stock was sold at an average price of $194.35, for a total transaction of $136,045.00. Following the sale, the director now owns 9,421 shares in the company, valued at approximately $1,830,971.35. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Terrence A. Duffy sold 35,000 shares of the company’s stock in a transaction dated Thursday, August 1st. The shares were sold at an average price of $200.15, for a total value of $7,005,250.00. Following the sale, the chief executive officer now owns 79,057 shares in the company, valued at approximately $15,823,258.55. The disclosure for this sale can be found here. Insiders sold a total of 88,873 shares of company stock worth $17,497,999 in the last quarter. Corporate insiders own 1.20% of the company’s stock.

Several institutional investors have recently made changes to their positions in CME. Truvestments Capital LLC acquired a new position in CME Group during the 1st quarter worth approximately $32,000. Close Asset Management Ltd acquired a new position in CME Group during the 1st quarter worth approximately $34,000. Advantage Investment Management LLC raised its stake in CME Group by 119.0% during the 2nd quarter. Advantage Investment Management LLC now owns 184 shares of the financial services provider’s stock worth $36,000 after buying an additional 100 shares during the period. Westside Investment Management Inc. acquired a new position in CME Group during the 2nd quarter worth approximately $38,000. Finally, Permanens Capital L.P. purchased a new stake in shares of CME Group in the first quarter worth approximately $41,000. Institutional investors own 84.58% of the company’s stock.

CME Group Company Profile (NASDAQ:CME)

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Featured Article: What is the price-to-earnings growth (PEG) ratio?

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.